Quantbot Technologies LP Increases Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Quantbot Technologies LP raised its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 6,924.3% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 14,751 shares of the biotechnology company's stock after buying an additional 14,541 shares during the period. Quantbot Technologies LP's holdings in Axon Enterprise were worth $8,767,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the stock. ZEGA Investments LLC purchased a new position in shares of Axon Enterprise in the 4th quarter valued at about $384,000. TD Private Client Wealth LLC increased its stake in shares of Axon Enterprise by 42.5% in the 4th quarter. TD Private Client Wealth LLC now owns 1,042 shares of the biotechnology company's stock valued at $619,000 after purchasing an additional 311 shares in the last quarter. Semanteon Capital Management LP purchased a new position in shares of Axon Enterprise in the 4th quarter valued at about $1,442,000. Whittier Trust Co. of Nevada Inc. increased its stake in shares of Axon Enterprise by 23.2% in the 4th quarter. Whittier Trust Co. of Nevada Inc. now owns 10,215 shares of the biotechnology company's stock valued at $6,071,000 after purchasing an additional 1,925 shares in the last quarter. Finally, Whittier Trust Co. increased its stake in shares of Axon Enterprise by 23.1% in the 4th quarter. Whittier Trust Co. now owns 19,469 shares of the biotechnology company's stock valued at $11,571,000 after purchasing an additional 3,649 shares in the last quarter. Hedge funds and other institutional investors own 79.08% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on AXON. Needham & Company LLC reiterated a "buy" rating and issued a $600.00 price objective on shares of Axon Enterprise in a report on Wednesday, February 26th. Robert W. Baird lifted their price objective on Axon Enterprise from $600.00 to $800.00 and gave the stock an "outperform" rating in a report on Friday, December 6th. Morgan Stanley upgraded Axon Enterprise from an "equal weight" rating to an "overweight" rating and lifted their price objective for the stock from $500.00 to $700.00 in a report on Tuesday, December 3rd. The Goldman Sachs Group lifted their price objective on Axon Enterprise from $500.00 to $700.00 and gave the stock a "buy" rating in a report on Monday, January 27th. Finally, Barclays reiterated a "hold" rating on shares of Axon Enterprise in a report on Monday, March 10th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and eleven have assigned a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $604.67.

Remove Ads

Axon Enterprise Trading Down 2.7 %

AXON traded down $14.83 during trading hours on Tuesday, reaching $539.99. The company's stock had a trading volume of 558,304 shares, compared to its average volume of 857,660. Axon Enterprise, Inc. has a fifty-two week low of $273.52 and a fifty-two week high of $715.99. The stock has a market cap of $41.38 billion, a PE ratio of 139.53, a P/E/G ratio of 5.17 and a beta of 1.12. The business's 50-day moving average is $593.10 and its 200-day moving average is $538.04. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63.

Insider Activity at Axon Enterprise

In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company's stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the transaction, the director now directly owns 6,929 shares in the company, valued at approximately $4,185,601.03. This represents a 6.10 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Jeffrey C. Kunins sold 1,035 shares of the business's stock in a transaction that occurred on Monday, December 23rd. The shares were sold at an average price of $624.47, for a total value of $646,326.45. Following the completion of the sale, the insider now directly owns 124,243 shares in the company, valued at approximately $77,586,026.21. The trade was a 0.83 % decrease in their position. The disclosure for this sale can be found here. 5.70% of the stock is currently owned by insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.